SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
America Stem Cell, Inc. Awarded a Phase I SBIR to Explore the Therapeutic Potential of Its Platform Technology (ASC-101) with Neural Stem Cells in Multiple Sclerosis Model